Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Osteosarcoma 1Neuroblastoma 1Lung Neoplasms 1Crohn Disease 1Chickenpox 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Adalimumab 4Etanercept 3secukinumab 1golimumab 1Vaccines 1Tumor Necrosis Factors 1Tai Ji 1Sulfasalazine 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Methods 1Meloxicam 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Exercise 1Etoricoxib 1Educational Status 1Early Intervention, Educational 1Celecoxib 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Spondylitis, Ankylosing × Herpes Zoster Vaccine × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡